Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 11 of 35

COMPLETED NA

SARS-COV-2 Screening in Dialysis Facilities

NCT05225298

COMPLETED NA

Validity of AI in Treatment of the Musculoskeletal Conditions by Vifive

NCT05290272

COMPLETED NA

Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes

NCT05777720

COMPLETED NA

The Effect of Exercise on Muscle Dysfunction in Cystinosis

NCT04071548

COMPLETED NA

Transcutaneous Electrical Nerve Stimulation for Pain Control During First-trimester Abortion

NCT05320432

COMPLETED NA

Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression

NCT05224063

COMPLETED NA

Ultrasound Therapy Effects to Modulate the Inflammatory Reflex

NCT05457907

TERMINATED NA

Microlearning Application for Diabetes Prevention

NCT05071820

COMPLETED NA

Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder

NCT05525390

TERMINATED NA

Feasibility of Text4US Program

NCT05509738

COMPLETED Phase 2

Paxlovid for Treatment of Long Covid

NCT05576662

COMPLETED NA

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

NCT05429203

COMPLETED NA

Wavefront-guided vs. Topography-guided LASIK

NCT05588882

COMPLETED NA

Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit

NCT05493982

COMPLETED NA

Text Message Reminders for Hearing Healthcare

NCT05438225

COMPLETED

Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study

NCT05295693

COMPLETED Phase 1

High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD)

NCT05587673

COMPLETED NA

Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit

NCT05521321

COMPLETED Phase 4

The BIomarker Guided (BIG) Study for Depression

NCT04181736

COMPLETED NA

Evaluating a Physician Opinion Leader Intervention to Increase Utilization of Coaching/Therapy During Residency

NCT05499468

COMPLETED NA

Effects of Post-Stroke Upper Extremity Assistance

NCT05036642

COMPLETED NA

Stationary Bike Use During Ice Bath and Virtual Reality

NCT05297838

COMPLETED NA

Facilitating Adaptive Expertise in Learning Computed Tomography

NCT05284838

TERMINATED NA

Pilot Study for PET/MR Imaging of Covid-19

NCT04954248

COMPLETED Phase 3

Mifepristone for Labor Induction

NCT05097326

COMPLETED NA

Device to Assist With Abdominal Access During Laparoscopic Surgery

NCT04392635

COMPLETED NA

Personalized Therapeutic Neuromodulation for Anhedonic Depression

NCT05144789

COMPLETED NA

Peer Motivation Coaches, Social Media-based Support Group, and Behavior Change Strategies to Decrease Prolonged Sitting and Increase Moderate Exercise Snacks

NCT05360485

COMPLETED NA

Spring Loaded Tri-Compartment Unloader Knee Brace Study

NCT05428332

COMPLETED Phase 3

Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery

NCT05027048

COMPLETED Phase 2

Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).

NCT05128929

COMPLETED NA

The Body Project: Comparing the Effectiveness of an In-person and Virtually Delivered Intervention.

NCT05794763

COMPLETED NA

Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia

NCT04885127

COMPLETED NA

Eating Disorder Prevention Program for Women With T1D

NCT05264376

COMPLETED

Understanding Performance: Enhancing Recovery as Surgeons

NCT05029674

COMPLETED NA

Twins Nutrition Study (TwiNS): Vegan vs. Omnivore

NCT05297825

COMPLETED NA

Pain Rehabilitation Virtual Reality (PRVR): Innovations to Enhance Mobility in the Presence of Pain

NCT04636177

COMPLETED NA

Multifamily Guided Self-Help Family-Based Treatment (MF-GSH-FBT)

NCT05446038

COMPLETED

Very Early Outcomes in Endoscopic Versus Open Carpal Tunnel Release

NCT07364604

COMPLETED NA

A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome

NCT04943276

COMPLETED NA

Transcervical Balloon Compared to Osmotic Dilators Prior to Surgical Abortion

NCT05099991

COMPLETED Phase 4

Lemborexant in Delayed Sleep Phase Syndrome

NCT05463861

COMPLETED NA

Communication and Marketing of School Meals

NCT05109351

COMPLETED Phase 1

Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation

NCT05282459

COMPLETED NA

Preventing Impaired Driving Among Adolescents

NCT04959461

COMPLETED NA

Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study

NCT05074667

COMPLETED NA

SZMN Blocks for Pain Control in Pediatric Patients Undergoing T&A

NCT04797559

COMPLETED

The CIA Score: a Learner's Tool

NCT05153265

COMPLETED NA

Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study

NCT05099679

COMPLETED Phase 1

Empagliflozin in Diuretic Refractory Ascites

NCT05013502

← Previous Page 11 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.